Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
Clinical trial NCT00895960 · TERMINATED
Trial details
- NCT number
- NCT00895960
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-07
- Primary completion
- 2013-08-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.